LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $285,219 | -16.4% | 4,760 | +0.6% | 0.00% | 0.0% |
| Q2 2023 | $341,033 | +13.9% | 4,730 | +16.2% | 0.00% | 0.0% |
| Q1 2023 | $299,389 | +10.1% | 4,070 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $271,876 | -21.0% | 4,070 | +2.0% | 0.00% | 0.0% |
| Q3 2022 | $344,000 | -32.7% | 3,990 | -30.4% | 0.00% | 0.0% |
| Q2 2022 | $511,000 | -22.9% | 5,730 | -2.7% | 0.00% | 0.0% |
| Q1 2022 | $663,000 | -27.1% | 5,890 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $910,000 | +0.8% | 5,890 | -9.1% | 0.00% | 0.0% |
| Q3 2021 | $903,000 | +6.2% | 6,478 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $850,000 | +2.4% | 6,478 | +18.9% | 0.00% | 0.0% |
| Q1 2021 | $830,000 | +60.9% | 5,447 | +5.0% | 0.00% | +100.0% |
| Q4 2020 | $516,000 | -78.5% | 5,187 | -79.4% | 0.00% | -80.0% |
| Q3 2020 | $2,396,000 | -0.0% | 25,133 | +17.3% | 0.01% | -16.7% |
| Q2 2020 | $2,397,000 | +267.6% | 21,430 | +139.0% | 0.01% | +200.0% |
| Q1 2020 | $652,000 | -30.3% | 8,967 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $935,000 | -3.0% | 8,967 | -7.4% | 0.00% | -33.3% |
| Q3 2019 | $964,000 | -20.3% | 9,687 | -8.5% | 0.00% | 0.0% |
| Q2 2019 | $1,209,000 | -11.8% | 10,587 | -2.8% | 0.00% | -25.0% |
| Q1 2019 | $1,370,000 | -12.6% | 10,897 | -5.6% | 0.00% | -20.0% |
| Q4 2018 | $1,567,000 | -54.2% | 11,547 | -7.3% | 0.01% | -44.4% |
| Q3 2018 | $3,419,000 | +21.5% | 12,457 | -8.2% | 0.01% | +12.5% |
| Q2 2018 | $2,813,000 | +26.3% | 13,577 | +0.7% | 0.01% | +33.3% |
| Q1 2018 | $2,228,000 | +11.6% | 13,487 | -7.5% | 0.01% | +20.0% |
| Q4 2017 | $1,996,000 | +23.1% | 14,580 | +22.4% | 0.01% | +25.0% |
| Q3 2017 | $1,622,000 | +12.2% | 11,910 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,446,000 | +14.7% | 11,910 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,261,000 | +5.3% | 11,910 | +1.0% | 0.00% | 0.0% |
| Q4 2016 | $1,198,000 | +0.7% | 11,790 | +1.1% | 0.00% | 0.0% |
| Q3 2016 | $1,190,000 | -18.4% | 11,660 | -4.7% | 0.00% | -20.0% |
| Q2 2016 | $1,459,000 | +16.1% | 12,230 | +4.2% | 0.01% | 0.0% |
| Q1 2016 | $1,257,000 | -19.2% | 11,741 | -18.1% | 0.01% | -16.7% |
| Q4 2015 | $1,555,000 | -2.1% | 14,341 | -22.7% | 0.01% | 0.0% |
| Q3 2015 | $1,589,000 | -15.2% | 18,558 | 0.0% | 0.01% | -14.3% |
| Q2 2015 | $1,873,000 | +40.4% | 18,558 | +7.3% | 0.01% | +40.0% |
| Q1 2015 | $1,334,000 | +28.6% | 17,298 | -11.2% | 0.01% | +66.7% |
| Q4 2014 | $1,037,000 | +10.6% | 19,486 | -2.3% | 0.00% | 0.0% |
| Q3 2014 | $938,000 | -28.6% | 19,952 | -5.4% | 0.00% | -25.0% |
| Q2 2014 | $1,314,000 | +6.5% | 21,092 | +14.9% | 0.00% | 0.0% |
| Q1 2014 | $1,234,000 | -4.7% | 18,349 | -25.5% | 0.00% | 0.0% |
| Q4 2013 | $1,295,000 | +18.6% | 24,622 | -2.4% | 0.00% | 0.0% |
| Q3 2013 | $1,092,000 | +6.1% | 25,237 | -8.2% | 0.00% | +33.3% |
| Q2 2013 | $1,029,000 | – | 27,487 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |